Expression of Concern: Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant BrainTumors (Malignant Brain Tumors, Stem Cells (2013) 31:8 (1706–1714) DOI: 10.1002/stem.1355);Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors

Stem Cells

Volumn 31, Issue 8, 2013, Pages 1706-1714

  Martinez Quintanilla, Jordi ^a   Bhere, Deepak ^a   Heidari, Pedram ^a   He, Derek ^a   Mahmood, Umar ^a   Shah, Khalid ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

Glioblastoma multiforme; Herpes simplex virus thymidine kinase; In vivo imaging; Stem cells; Tumor necrosis factor apoptosis inducing ligand

Indexed keywords

CASPASE; GANCICLOVIR; THYMIDINE KINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CELL DEATH; CELL ENGINEERING; CELL FATE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; STEM CELL; TUMOR CELL; TUMOR GROWTH;

MUS; SIMPLEXVIRUS;

GLIOBLASTOMA MULTIFORME; HERPES SIMPLEX VIRUS THYMIDINE KINASE; IN VIVO IMAGING; STEM CELLS; TUMOR NECROSIS FACTOR APOPTOSIS-INDUCING LIGAND;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; GANCICLOVIR; GENETIC ENGINEERING; GLIOBLASTOMA; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; SIMPLEXVIRUS; THYMIDINE KINASE; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84883428891     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1093/stmcls/sxae012     Document Type: Erratum

References (47)

1. Sathornsumetee S, Rich JN. New approaches to primary brain tumor treatment. Anticancer Drugs 2006;17:1003-1016.
2. Shah K. Mesenchymal stem cells engineered for cancer therapy. Adv Drug Deliv Rev 2012;64:739-748.
3. Nakamizo A, Marini F, Amano T et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005;65:3307-3318.
4. Miletic H, Fischer Y, Litwak S et al. Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther 2007;15:1373-1381.
5. Nakamura K, Ito Y, Kawano Y et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004;11:1155-1164.
6. Almasan A, Ashkenazi A. Apo2l/trail: Apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 2003; 14:337-348.
7. Shah K, Bureau E, Kim DE et al. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol 2005;57:34-41.
8. Kauer TM, Figueiredo JL, Hingtgen S et al. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Nat Neurosci 2011.
9. Fillat C, Carrio M, Cascante A et al. Suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene/ganciclovir system: Fifteen years of application. Curr Gene Ther 2003;3:13-26.
10. Tjuvajev JG, Doubrovin M, Akhurst T et al. Comparison of radiolabeled nucleoside probes (fiau, fhbg, and fhpg) for pet imaging of hsv1-tk gene expression. J Nucl Med 2002;43:1072-1083.
11. Hung SC, Deng WP, Yang WK et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 2005;11:7749-7756.
12. Gambhir SS, Bauer E, Black ME et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 2000;97:2785-2790.
13. Tjuvajev JG, Avril N, Oku T et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 1998;58:4333-4341.
14. Nagano H, Miyamoto A, Wada H et al. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules. Cancer 2007;110: 2493-2501.
15. Kucerova L, Altanerova V, Matuskova M et al. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007;67:6304-6313.
16. Cavarretta IT, Altanerova V, Matuskova M et al. Adipose tissuederived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth. Mol Ther 2010;18:223-231.
17. Aboody KS, Brown A, Rainov NG et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000;97:12846-12851.
18. Ito S, Natsume A, Shimato S et al. Human neural stem cells transduced with ifn-beta and cytosine deaminase genes intensify bystander effect in experimental glioma. Cancer Gene Ther 2010;17:299-306.
19. Rath P, Shi H, Maruniak JA et al. Stem cells as vectors to deliver hsv/tk gene therapy for malignant gliomas. Curr Stem Cell Res Ther 2009;4:44-49.
20. Sasportas LS, Kasmieh R, Wakimoto H et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci USA 2009;106:4822-4827.
21. Sena-Esteves M, Tebbets JC, Steffens S et al. Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 2004;122:131-139.
22. Shah K, Hingtgen S, Kasmieh R et al. Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. J Neurosci 2008;28:4406-4413.
23. Corsten MF, Miranda R, Kasmieh R et al. Microrna-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered s-trail in human gliomas. Cancer Res 2007;67:8994-9000.
24. Lee RH, Pulin AA, Seo MJ et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein tsg-6. Cell Stem Cell 2009;5:54-63.
25. Uchibori R, Okada T, Ito T et al. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy. J Gene Med 2009;11:373-381.
26. Kim SM, Lim JY, Park SI et al. Gene therapy using trail-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 2008;68:9614-9623.
27. Hotte SJ, Hirte HW, Chen EX et al. A phase 1 study of mapatumumab (fully human monoclonal antibody to trail-r1) in patients with advanced solid malignancies. Clin Cancer Res 2008;14:3450-3455.
28. Greco FA, Bonomi P, Crawford J et al. Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the trail receptor-1, in patients with advanced non-small cell lung cancer. Lung Cancer 2008;61:82-90.
29. Asselin MC, O'Connor JP, Boellaard R et al. Quantifying heterogeneity in human tumours using MRI and PET. Eur J Cancer 2012;48: 447-455.
30. Tyler MA, Ulasov IV, Sonabend AM et al. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Ther 2009;16:262-278.
31. Ahmed AU, Thaci B, Alexiades NG et al. Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. Mol Ther 2011;19: 1714-1726.
32. Thaci B, Ahmed AU, Ulasov IV et al. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: Targeted delivery of the therapeutic payload in an orthotopic brain tumor model. Cancer Gene Ther 2012;19:431-442.
33. Karnoub AE, Dash AB, Vo AP et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449: 557-563.
34. Zhu W, Xu W, Jiang R et al. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 2006; 80:267-274.
35. Niess H, Bao Q, Conrad C et al. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. Ann Surg 2011;254:767-774, discussion 774-765.
36. Ramos CA, Asgari Z, Liu E et al. An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies. Stem Cells 2010;28:1107-1115.
37. Sun N, Lee A, Wu JC. Long term non-invasive imaging of embryonic stem cells using reporter genes. Nat Protoc 2009;4:1192-1201.
38. Bridgewater JA, Springer CJ, Knox RJ et al. Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug cb1954. Eur J Cancer 1995; 31A:2362-2370.
39. Huch M, Abate-Daga D, Roig JM et al. Targeting the cyp2b 1/cyclophosphamide suicide system to fibroblast growth factor receptors results in a potent antitumoral response in pancreatic cancer models. Hum Gene Ther 2006;17:1187-1200.
40. Alieva M, Bago JR, Aguilar E et al. Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response. Plos One 2012;7:e35148.
41. Bipat S, Niekel MC, Comans EF et al. Imaging modalities for the staging of patients with colorectal cancer. Neth J Med 2012;70:26-34.
42. Morgan B. Opportunities and pitfalls of cancer imaging in clinical trials. Nat Rev Clin Oncol 2011;8:517-527.
43. Thu MS, Najbauer J, Kendall SE et al. Iron labeling and pre-clinical mri visualization of therapeutic human neural stem cells in a murine glioma model. Plos One 2009;4:e7218.
44. Loebinger MR, Kyrtatos PG, Turmaine M et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009;69: 8862-8867.
45. Pawelczyk E, Arbab AS, Chaudhry A et al. In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: Implications for cellular therapy. Stem Cells 2008;26:1366-1375.
46. Amsalem Y, Mardor Y, Feinberg MS et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007;116:I38-45.
47. Terrovitis J, Stuber M, Youssef A et al. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 2008;117:1555-1562.